trending Market Intelligence /marketintelligence/en/news-insights/trending/jveb2akvbpr05g7_1w7whq2 content esgSubNav
In This List

Onconova Therapeutics appoints chief medical officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Onconova Therapeutics appoints chief medical officer

Onconova Therapeutics Inc. named Richard Woodman as chief medical officer and senior vice president of research and development.

Woodman was most recently with Novartis AG as senior vice president and head of U.S. oncology clinical development and medical affairs. Prior to that, he was Novartis Oncology's franchise head for hematology in global medical affairs.

Newtown, Pa.-based is a biopharmaceutical company focused on the discovery and development of small molecule drug candidates to treat cancer.